SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRobert Walters Regulatory News (RWA)

Share Price Information for Robert Walters (RWA)

Share Price is delayed by 15 minutes
Get Live Data
85.00    1.00 (1.19%)
Bid:
84.00
Ask:
89.20
Spread: 5.20 (6.19%)
Market Cap: £55.91m
RWA Live PriceLast checked at - London Stock Exchange

Intraday Robert Walters Share Chart

Director/PDMR Shareholding

12 Oct 2017 17:53

RNS Number : 4964T
Robert Walters PLC
12 October 2017
 

12 October 2017

ROBERT WALTERS PLC

(the "Company")

Directors' Shareholdings

 

The Company was informed on 12 October 2017 of the following dealings by certain Directors in ordinary shares of 20p each of the Company ("Ordinary Shares") that occurred on the same date.

 

Robert Walters, Chief Executive Officer of the Company, and Giles Daubeney, Deputy Chief Executive Officer of the Company, exercised options to purchase Ordinary Shares under the terms of The Robert Walters Executive Share Option Scheme as outlined in the table below:

 

Director

Number of Awards exercised

Exercise

price (p)

Number of shares sold

Sale price (p)

Net increase in shareholdings

 

Robert Walters

 

300,000

 

208

 

300,000

 

580

 

-

 

Robert Walters

 

300,000

 

211

 

300,000

 

580

 

-

 

Giles Daubeney

 

250,000

 

208

 

250,000

 

580

 

-

 

Giles Daubeney

 

250,000

 

211

 

250,000

 

580

 

-

 

The Company also received notice that on 12 October 2017, Robert Walters, sold an additional 392,581 Ordinary Shares at a price of 580p per share. On the same date Giles Daubeney, Deputy Chief Executive Officer of the Company, sold an additional 150,000 Ordinary Shares also at a price of 580p per share.

 

In aggregate, Robert Walters and Giles Daubeney have therefore today sold 992,581 Ordinary Shares and 650,000 Ordinary Shares respectively at a price of 580p per Ordinary Share.

 

As a result of the exercise of these share options and subsequent share sales, there has therefore been a change in the overall shareholdings of each of these Directors as set out below:

 

Director

Shareholding prior to this announcement

% holding in Company

Shareholding after this announcement

% holding in Company

Robert Walters

2,617,205

3.51

2,224,624

2.96

Giles Daubeney

1,883,069

2.53

1,733,069

2.30

 

Robert Walters plc's issued share capital consists of 79,340,740 Ordinary Shares with voting rights. Robert Walters plc holds 4,074,000 Ordinary Shares in Treasury.

 

Therefore, the total number of voting rights in Robert Walters plc is 75,266,740.

 

The above figure of 75,266,740 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Robert Walters plc under the FSA's Disclosure and Transparency Rules.

 

 

 

 

 

 

 

APPENDIX

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Robert Walters

2.

Reason for the notification

(a)

Position/status

Chief Executive Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Robert Walters plc

(b)

LEI

213800LIE15BDEN3VW43

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary Shares of 20p each

(b)

Identification code of the Financial Instrument

ISIN Code : GB0008475088

(c)

Nature of the transaction

Exercise of option to purchase shares under the terms of Robert Walters Executive Share Option Scheme and the on-market sale of ordinary shares in Robert Walters plc.

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

208p

300,000

211p

300,000

580p

992,581

(e)

Aggregated information

- Aggregated volume

- Price

 

300,000 (exercised) at 208p

300,000 (exercised) at 211p

992,581 (sold) at 580p

 

(f)

Date of the transaction

12 October 2017

(g)

Place of the transaction

London Stock Exchange

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Giles Daubeney

2.

Reason for the notification

(a)

Position/status

Deputy Chief Executive Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Robert Walters plc

(b)

LEI

213800LIE15BDEN3VW43

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary Shares of 20p each

(b)

Identification code of the Financial Instrument

ISIN Code : GB0008475088

(c)

Nature of the transaction

Exercise of option to purchase shares under the terms of Robert Walters Executive Share Option Scheme and the on-market sale of ordinary shares in Robert Walters plc.

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

208p

250,000

211p

250,000

580p

650,000

(e)

Aggregated information

- Aggregated volume

- Price

 

250,000 (exercised) at 208p

250,000 (exercised) at 211p

650,000 (sold) at 580p

 

(f)

Date of the transaction

12 October 2017

(g)

Place of the transaction

London Stock Exchange

 

Enquiries:

Robert Walters plc

Robert Walters, Chief Executive

Alan Bannatyne, Chief Financial Officer +44 20 7379 3333

 

Newgate Communications

Steffan Williams

Charlotte Coulson +44 20 7680 6550

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFERILLFLID
Date   Source Headline
14th May 20269:24 amRNSDirector/PDMR Shareholding
13th May 202610:40 amRNSDirector/PDMR Shareholding
5th May 202612:32 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSDirector/PDMR Shareholding
30th Apr 20263:16 pmRNSResult of AGM
30th Apr 202610:27 amRNSDirectorate change
28th Apr 202610:10 amRNSDirector/PDMR Shareholding
24th Apr 20269:34 amRNSDirector/PDMR Shareholding
17th Apr 20269:03 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSQ1 2026 Trading Update
14th Apr 20265:35 pmRNSBLOCK LISTING SIX MONTHLY RETURN
14th Apr 20263:46 pmRNSHolding(s) in Company
1st Apr 20266:12 pmRNSAnnual Financial Report
30th Mar 20267:00 amRNSBoard and Management Changes
27th Mar 20262:56 pmRNSHolding(s) in Company
27th Mar 20262:54 pmRNSHolding(s) in Company
23rd Mar 20269:21 amRNSHolding(s) in Company
17th Mar 202610:00 amRNSHolding(s) in Company
11th Mar 20267:00 amRNS2025 Full-Year Results
3rd Feb 20264:08 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSQ4 2025 Trading Update
18th Dec 20257:00 amRNSAppointment of Non-Executive Director
18th Nov 20255:10 pmRNSHolding(s) in Company
17th Nov 20255:00 pmRNSHolding(s) in Company
6th Nov 20258:55 amRNSBLOCK LISTING SIX-MONTHLY RETURN
14th Oct 20257:00 amRNSQ3 2025 Trading Update
11th Sep 20253:06 pmRNSHolding(s) in Company
8th Aug 20252:33 pmRNSHolding(s) in Company
31st Jul 20257:00 amRNS2025 Half-Year Results
23rd Jul 20254:56 pmRNSHolding(s) in Company
23rd Jul 20254:54 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSQ2 2025 Trading Update
9th Jun 20252:11 pmRNSHolding(s) in Company
4th Jun 20253:49 pmRNSHolding(s) in Company
2nd Jun 20252:50 pmRNSHolding(s) in Company
30th Apr 20254:09 pmRNSHolding(s) in Company
29th Apr 20252:59 pmRNSResult of 2025 Annual General Meeting
16th Apr 202512:06 pmRNSDirector/PDMR Shareholding
15th Apr 20257:00 amRNSQ1 2025 Trading Update
28th Mar 202511:00 amRNSAnnual Report and Annual General Meeting
12th Mar 202511:47 amRNSDirector/PDMR Shareholding
7th Mar 20259:28 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNS2024 full-year results
14th Feb 20257:00 amRNSHolding(s) in Company
16th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSQ4 2024 Trading Update
10th Jan 20254:22 pmRNSHolding(s) in Company
17th Dec 20244:32 pmRNSHolding(s) in Company
13th Dec 202411:06 amRNSHolding(s) in Company
11th Dec 20247:00 amRNSAppointment of Joint Corporate Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.